Skip to main navigation Skip to search Skip to main content

Nanomedicine as an innovative therapeutic strategy for pediatric cancer

  • Essa Mohd Aleassa
  • , Malcolm Xing
  • , Richard Keijzer

Research output: Contribution to journalReview articlepeer-review

Abstract

Childhood cancer is the leading cause of mortality in children between 1 and 14 years of age. Malignancy accounts for 18 % of overall childhood mortality. Therapeutic advances in the field of pediatric oncology have helped to increase survival. Nanotechnology is the modification of materials at a nanoscale and can be used to deliver therapeutic agents. Examples of nanotechnology applications are organic self-assembled amphiphilic polymers, non-organic nanocarriers such as nanotubes and quantum dots. Each of these has their own utility in different settings. Application of nanotechnology in medicine has been extensively studied. Examples of pediatric tumors that received special attention are: neuroblastoma, retinoblastoma, central nervous system tumors and musculoskeletal tumors. This review will summarize the application of nanomedicine as an innovative management strategy in pediatric oncology.

Original languageEnglish
Pages (from-to)611-616
Number of pages6
JournalPediatric Surgery International
Volume31
Issue number7
DOIs
Publication statusPublished - Jul 12 2015
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Cancer
  • Nanomedicine
  • Pediatric surgery

ASJC Scopus subject areas

  • Surgery
  • Pediatrics, Perinatology, and Child Health

Fingerprint

Dive into the research topics of 'Nanomedicine as an innovative therapeutic strategy for pediatric cancer'. Together they form a unique fingerprint.

Cite this